Schonfeld Strategic Advisors’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-630
Closed -$10K 2174
2021
Q3
$10K Sell
630
-190,780
-100% -$9.16M ﹤0.01% 2083
2021
Q2
$17.7M Buy
191,410
+23,705
+14% +$1.51M 0.2% 152
2021
Q1
$8.72M Buy
167,705
+150,246
+861% +$7.09M 0.12% 261
2020
Q4
$471K Sell
17,459
-2,931
-14% -$74.3K 0.01% 1052
2020
Q3
$571K Buy
+20,390
New +$408K 0.01% 875
2019
Q3
Sell
-62,785
Closed -$1.88M 1032
2019
Q2
$1.88M Buy
+62,785
New +$1.88M 0.07% 303
2019
Q1
Sell
-47,518
Closed -$1.35M 1058
2018
Q4
$1.35M Buy
47,518
+8,613
+22% +$275K 0.05% 403
2018
Q3
$1.67M Buy
+38,905
New +$1.52M 0.07% 323

Other funds holding CARM